8:47 AM
Aug 23, 2018
 |  BC Innovations  |  Distillery Therapeutics


INDICATION: Lymphoma; acute lymphoblastic leukemia (ALL); ovarian cancer; solid tumors

Cell culture and mouse studies suggest anti-PD-1 single-chain variable fragment (scFv)-secreting CAR T cells could help treat Burkitt lymphoma, ALL and solid tumors. In co-culture with human Burkitt lymphoma or ALL...

Read the full 180 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >